Transplant Diagnostics Market Size is Expected to Grow at a CAGR of 8% During the Forecast Period 2022-2030 |  Growth Plus Reports

Transplant Diagnostics Market Size is Expected to Grow at a CAGR of 8% During the Forecast Period 2022-2030 | Growth Plus Reports

Pune, Nov. 14, 2022 (GLOBE NEWSWIRE) — According to the latest report released by Growth Plus Reports, the Transplant Diagnostics Market clock $1.98 billion by 2030. The rapidly increasing adoption of digitalization due to growing urbanization is a major driver for the transplant diagnostics market. This exclusive information is published by Growth Plus Reports in its report titled “Transplant Diagnostics Market – Global Outlook and Forecast 2022-2030

Get a sample PDF brochure:

Market factors

With the increasing prevalence of chronic diseases that can cause organ failure, it is expected that the uptake of transplant diagnostics (including pre- and post-transplant screening) will increase dramatically. Due to the multiple advantages that these tests offer in determining the viability of the organ transplant procedure, the market has attracted the attention of medical professionals. Organ transplant management now has access to improved diagnostic alternatives thanks to major technological advances in transplant diagnosis. The market is mature in industrialized countries, but there are potential markets for transplant diagnostics in developing countries like LAMEA and Asia-Pacific. In addition, the increase in the geriatric population, the growing prevalence of chronic diseases, the increase in laboratory automation of robot-assisted diagnostic procedures, and technological advances in human leukocyte antigen typing are some key factors propelling the growth of the global stem cell, soft tissue and strong transplantation markets.

Excerpts from ‘Segmentation by Type’

On the basis of transplant type, the transplant diagnostics market has been segmented into

  • solid organ
  • Stem cell
  • soft handkerchief

The solid organ transplant segment led the segment during the forecast period. During the projected period, the solid organ transplantation segment is expected to hold a large proportion. Since its inception as an experimental procedure in the 20th century, today solid organ transplantation is recognized as a well-recognized and useful treatment option for patients with end-stage organ disease. The kidneys are the organ that receives the most transplants, followed by the liver. In February 2022, the Health Resources and Services Administration reported that there were over 106,000 people on the United States National Transplant Waitlist for solid organ transplants. The kidney (83%) is the organ with the longest waiting time, followed by the liver (11%), pancreas (1%), heart (3%) and others (2%). Increased testing is required for transplantation owing to the increase in demand for solid organs, which is expected to propel the growth of the segment over the forecast period. The expansion of this market will also be driven by the growing adoption of organ transplant testing, which is another factor. For example, Prospera with Quantification, a cell-free DNA (cfDNA) test for kidney rejection, was introduced by Natera Inc. in September 2021. Natera Inc. is a leader in transforming healthcare through testing genetics and cfDNA.

Excerpts from ‘Segmentation by region’

Based on region, the transplant diagnostics market has been segmented into

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

The transplant diagnostics market is expected to be dominated by North America, and this trend is expected to continue throughout the projected period. Countries in the region, including the United States and Canada, are well equipped with the infrastructure, sponsored organizations, and government involvement to encourage organ transplantation for patients. For example, the National Institute of Health reported in May 2022 that the projected budget for transplant research in 2020, 2021, and 2022 was $721 million, $702 million, and $735 million. Greater adoption of transplant diagnostics and market growth in this region will result from increased funding for transplant research. Additionally, more than 40,000 organ transplants took place in the United States in 2021, according to the Organ Donation Statistics report published in February 2022. Thus, over the projection period, the increase in transplants will fuel the market expansion.

Excerpts from “Competitive Landscape”

Some of the major players in the global transplant diagnostics market include

  • ThermoFisher Scientific, Inc.
  • Bioscience Liaison
  • Illumina, Inc.
  • F. Hoffmann La-Roche Ag.
  • Abbott Laboratories, Inc.
  • Qiagen AG
  • Sigma–Aldrich
  • Immucor Transplant Diagnostics, Inc.
  • Biomerieux Sa
  • Bio-Rad Laboratories, Inc.
  • Affymetrix, Inc.
  • Omixon Ltd.

Find out before you buy this research report:


    1. Market ecosystem
    2. Schedule under study
      1. Historical years – 2020
      2. Base year – 2021
      3. Planned years – 2022 to 2030
    3. Currency used in the report
    1. Research approach
    2. Data collection methodology
    3. Information source
      1. Secondary sources
      2. Primary sources
    4. Market estimation approach
      1. From bottom to top
      2. From top to bottom
    5. Market Forecast Model
    6. Limits and assumptions
    1. Current market trends (COVID-19 outlook)
    2. Key players and competitive positioning (2021)
    1. Drivers
    2. Constraints/Challenges
    3. Opportunities
    1. Probiotic supplements
    2. herbal supplements
    3. Vitamin and mineral supplements
      1. Vitamin C supplements
      2. Vitamin D supplements
      3. Vitamin B complex supplements
      4. Multivitamins
      5. Selenium supplements
      6. Zinc supplements
      7. Others
    4. Others
    1. gut health
    2. hair growth
    3. Respiratory tract infection
    4. Others
    1. capsules
    2. Freeze
    3. capsule
    4. Tablets
    5. Powder
    6. Liquid
    7. Others

TOC Continue…


  • Fueled by free analyst hours and expert interviews with every report
  • Comprehensive quantitative and qualitative information at segment and sub-segment level
  • Trends and perspectives of the impact of Covid 19
  • Granular information at global/regional/country level
  • In-depth insights into market dynamics (drivers, restraints, opportunities) and business environment
  • Global coverage of the competitive landscape
  • Winning imperatives
  • Comprehensive coverage of “strategic developments” recorded by major market players


  • Distributor Landscape Assessment
  • Pipeline assessment
  • Pricing information
  • Customer evaluation
  • Analysis of investments and initiatives
  • ‘Company Profile’ of key players

Buy Now Full Report:

About Us

Growth+Reports is part of GRG Health, a global healthcare knowledge services company. We are proud members of the EPhMRA (European Pharmaceutical Marketing Research Association).

The Growth+ portfolio of services leverages our core capabilities in secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable and game-changing solutions. that prepare them for future growth and success.

We have been recognized by the prestigious CEO Magazine as “The Most Innovative Market Research Company in the Healthcare Market of 2020.


#Transplant #Diagnostics #Market #Size #Expected #Grow #CAGR #Forecast #Period #Growth #Reports

Leave a Comment

Your email address will not be published. Required fields are marked *